RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Collplant Biotechnologies Stock

Collplant Biotechnologies EBIT 2024

Collplant Biotechnologies EBIT

-17.33 M USD

Ticker

CLGN

ISIN

US19516R1077

WKN

A2PMPX

In 2024, Collplant Biotechnologies's EBIT was -17.33 M USD, a 160.71% increase from the -6.65 M USD EBIT recorded in the previous year.

The Collplant Biotechnologies EBIT history

YEAREBIT (undefined USD)
2026e-551.82
2025e-6,550.44
2024e-17,326.74
2023-6,646
2022-16,800
2021440
2020-5,600
2019-7,630
2018-4,250

Collplant Biotechnologies Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Collplant Biotechnologies, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Collplant Biotechnologies from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Collplant Biotechnologies’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Collplant Biotechnologies. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Collplant Biotechnologies’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Collplant Biotechnologies’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Collplant Biotechnologies’s growth potential.

Collplant Biotechnologies Revenue, EBIT and net profit per share

DateCollplant Biotechnologies RevenueCollplant Biotechnologies EBITCollplant Biotechnologies Net Income
2026e20.24 M undefined-551,820 undefined-291,975 undefined
2025e13.26 M undefined-6.55 M undefined-4.61 M undefined
2024e1.72 M undefined-17.33 M undefined-14.66 M undefined
202310.96 M undefined-6.65 M undefined-7.02 M undefined
2022300,000 undefined-16.8 M undefined-16.93 M undefined
202115.64 M undefined440,000 undefined240,000 undefined
20206.14 M undefined-5.6 M undefined-5.77 M undefined
20192.32 M undefined-7.63 M undefined-11.16 M undefined
20185.01 M undefined-4.25 M undefined-6.25 M undefined

Collplant Biotechnologies stock margins

The Collplant Biotechnologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Collplant Biotechnologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Collplant Biotechnologies.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Collplant Biotechnologies's sales revenue. A higher gross margin percentage indicates that the Collplant Biotechnologies retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Collplant Biotechnologies's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Collplant Biotechnologies's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Collplant Biotechnologies's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Collplant Biotechnologies. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Collplant Biotechnologies's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Collplant Biotechnologies Margin History

Collplant Biotechnologies Gross marginCollplant Biotechnologies Profit marginCollplant Biotechnologies EBIT marginCollplant Biotechnologies Profit margin
2026e89.73 %-2.73 %-1.44 %
2025e89.73 %-49.4 %-34.79 %
2024e89.73 %-1,006.2 %-851.17 %
202389.73 %-60.64 %-64.05 %
202266.67 %-5,600 %-5,643.33 %
202189.51 %2.81 %1.53 %
202051.14 %-91.21 %-93.97 %
201918.97 %-328.88 %-481.03 %
201867.07 %-84.83 %-124.75 %

Collplant Biotechnologies Aktienanalyse

What does Collplant Biotechnologies do?

CollPlant Biotechnologies Ltd is a biotechnology company specializing in the development and production of collagen-based products. The company was founded in 2004 and is headquartered in Rehovot, Israel. The company's history is rooted in collagen research. Collagen is an important component of connective tissue, providing structure and strength. The company specializes in the use of plant-based collagen derived from a specific plant called Nicotiana tabacum. Plant-based collagen has the advantage of being biocompatible, biodegradable, and more cost-effective than animal-based collagen. CollPlant Biotechnologies' business model is to develop and sell collagen-based products for various industries. The company's main sectors are medicine, cosmetics, and 3D printing. Each sector offers its own products and has different requirements for collagen. In the medicine sector, CollPlant Biotechnologies offers collagen-based products for wound healing, bone regeneration, and treatment of skin diseases. The advantage of plant-based collagen is that it causes very few allergic reactions and is well tolerated. In the cosmetics sector, the company develops collagen-based products for skincare, particularly for reducing wrinkles and fine lines. CollPlant Biotechnologies also has its own cosmetics brand called "Verifeel," which offers collagen-based creams and serums. The 3D printing sector is a relatively new initiative for the company. Here, CollPlant Biotechnologies develops collagen-based materials that can be used for 3D printing of biological tissues and organs. The advantage of plant-based collagen in 3D printing is that it is highly moldable and biocompatible. CollPlant Biotechnologies also has a partnership with one of the world's largest tobacco companies, Philip Morris International. Together, they are working to produce plant-based collagen on an industrial scale. Overall, CollPlant Biotechnologies has a promising future. The company has specialized in a unique niche in the biotechnology sector and offers a variety of products for different industries. With the partnership with Philip Morris International and the development of 3D printing materials, the company also has other exciting opportunities for the future. Collplant Biotechnologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Collplant Biotechnologies's EBIT

Collplant Biotechnologies's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Collplant Biotechnologies's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Collplant Biotechnologies's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Collplant Biotechnologies’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Collplant Biotechnologies stock

How much did Collplant Biotechnologies achieve in EBIT for the current year?

In the current year, Collplant Biotechnologies has achieved an EBIT of -17.33 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Collplant Biotechnologies.

How has the EBIT of Collplant Biotechnologies developed in recent years?

The EBIT of Collplant Biotechnologies has increased by 160.709% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Collplant Biotechnologies?

The EBIT of Collplant Biotechnologies is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Collplant Biotechnologies pay?

Over the past 12 months, Collplant Biotechnologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Collplant Biotechnologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Collplant Biotechnologies?

The current dividend yield of Collplant Biotechnologies is .

When does Collplant Biotechnologies pay dividends?

Collplant Biotechnologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Collplant Biotechnologies?

Collplant Biotechnologies paid dividends every year for the past 0 years.

What is the dividend of Collplant Biotechnologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Collplant Biotechnologies located?

Collplant Biotechnologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Collplant Biotechnologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Collplant Biotechnologies from 9/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Collplant Biotechnologies pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of Collplant Biotechnologies in the year 2023?

In the year 2023, Collplant Biotechnologies distributed 0 USD as dividends.

In which currency does Collplant Biotechnologies pay out the dividend?

The dividends of Collplant Biotechnologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Collplant Biotechnologies

Our stock analysis for Collplant Biotechnologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Collplant Biotechnologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.